FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204159204> ?p ?o ?g. }

• W3204159204 endingPage "705" @default.
• W3204159204 startingPage "698" @default.
• W3204159204 abstract "Objective: To assess outcomes of women with uterine fibroids (UFs) and heavy menstrual bleeding (HMB) treated with 300 mg elagolix twice daily plus add-back therapy (E2 1 mg/NETA 0.5 mg once daily) or placebo who were not considered responders in pooled analysis of two phase 3, 6-month randomized clinical trials (Elaris UF-1 and UF-2). Methods: Responders were defined as women who met both primary end point bleeding criteria (<80 mL menstrual blood loss [MBL] during the final month and ≥50% reduction in MBL from baseline to the final month) and either completed the study or discontinued due to predefined reasons. Thus, women termed nonresponders who were analyzed in this study who met neither or one bleeding end point or met both criteria but prematurely discontinued treatment because of adverse events, perceived lack of efficacy, or required surgical or interventional treatment for UFs were analyzed in this study. This post hoc analysis assessed mean changes from baseline in MBL, as well as adverse events. Results: Among 367 women receiving elagolix with add-back with observed data, 89 (24%) were not considered responders. Within this subset, 17 (19%) women met both bleeding criteria but prematurely discontinued treatment for the reasons mentioned above, while 23 (26%) met one bleeding criterion and 49 (55%) met neither bleeding criteria, regardless of discontinuation status. Among all nonresponders, a numerical trend toward greater mean reductions in MBL was observed in those receiving elagolix with add-back, compared with placebo group nonresponders. No differences in adverse events were observed between responders and nonresponders. Conclusion: Forty of 89 (45%) women with HMB and UFs who were classified as nonresponders in the UF-1 or UF-2 trials may have had a clinically meaningful response to elagolix with add-back therapy because they met at least one of the objective bleeding criteria. Clinical Trial Registration: Clinicaltrials.gov, NCT02654054 and NCT02691494. (NEJM 2020; 382:328-340) DOI: 10.1056/NEJMoa1904351." @default.
• W3204159204 created "2021-10-11" @default.
• W3204159204 creator A5003343672 @default.
• W3204159204 creator A5035004418 @default.
• W3204159204 creator A5036877943 @default.
• W3204159204 creator A5053242908 @default.
• W3204159204 creator A5056214143 @default.
• W3204159204 creator A5058749241 @default.
• W3204159204 creator A5069862942 @default.
• W3204159204 creator A5071868535 @default.
• W3204159204 creator A5078809545 @default.
• W3204159204 creator A5081489339 @default.
• W3204159204 creator A5091735482 @default.
• W3204159204 date "2022-05-01" @default.
• W3204159204 modified "2023-09-30" @default.
• W3204159204 title "Reduction of Heavy Menstrual Bleeding in Women Not Designated as Responders to Elagolix Plus Add Back Therapy for Uterine Fibroids" @default.
• W3204159204 cites W1963831711 @default.
• W3204159204 cites W2014889311 @default.
• W3204159204 cites W2047951575 @default.
• W3204159204 cites W2602082991 @default.
• W3204159204 cites W2888311000 @default.
• W3204159204 cites W3002354512 @default.
• W3204159204 cites W3044716658 @default.
• W3204159204 cites W4244565353 @default.
• W3204159204 cites W4302314408 @default.
• W3204159204 doi "https://doi.org/10.1089/jwh.2021.0152" @default.
• W3204159204 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34582715" @default.
• W3204159204 hasPublicationYear "2022" @default.
• W3204159204 type Work @default.
• W3204159204 sameAs 3204159204 @default.
• W3204159204 citedByCount "2" @default.
• W3204159204 countsByYear W32041592042022 @default.
• W3204159204 countsByYear W32041592042023 @default.
• W3204159204 crossrefType "journal-article" @default.
• W3204159204 hasAuthorship W3204159204A5003343672 @default.
• W3204159204 hasAuthorship W3204159204A5035004418 @default.
• W3204159204 hasAuthorship W3204159204A5036877943 @default.
• W3204159204 hasAuthorship W3204159204A5053242908 @default.
• W3204159204 hasAuthorship W3204159204A5056214143 @default.
• W3204159204 hasAuthorship W3204159204A5058749241 @default.
• W3204159204 hasAuthorship W3204159204A5069862942 @default.
• W3204159204 hasAuthorship W3204159204A5071868535 @default.
• W3204159204 hasAuthorship W3204159204A5078809545 @default.
• W3204159204 hasAuthorship W3204159204A5081489339 @default.
• W3204159204 hasAuthorship W3204159204A5091735482 @default.
• W3204159204 hasBestOaLocation W32041592041 @default.
• W3204159204 hasConcept C126322002 @default.
• W3204159204 hasConcept C142724271 @default.
• W3204159204 hasConcept C168563851 @default.
• W3204159204 hasConcept C197934379 @default.
• W3204159204 hasConcept C203092338 @default.
• W3204159204 hasConcept C204787440 @default.
• W3204159204 hasConcept C27081682 @default.
• W3204159204 hasConcept C2778715236 @default.
• W3204159204 hasConcept C2780566971 @default.
• W3204159204 hasConcept C29456083 @default.
• W3204159204 hasConcept C2992922752 @default.
• W3204159204 hasConcept C2993353421 @default.
• W3204159204 hasConcept C71924100 @default.
• W3204159204 hasConceptScore W3204159204C126322002 @default.
• W3204159204 hasConceptScore W3204159204C142724271 @default.
• W3204159204 hasConceptScore W3204159204C168563851 @default.
• W3204159204 hasConceptScore W3204159204C197934379 @default.
• W3204159204 hasConceptScore W3204159204C203092338 @default.
• W3204159204 hasConceptScore W3204159204C204787440 @default.
• W3204159204 hasConceptScore W3204159204C27081682 @default.
• W3204159204 hasConceptScore W3204159204C2778715236 @default.
• W3204159204 hasConceptScore W3204159204C2780566971 @default.
• W3204159204 hasConceptScore W3204159204C29456083 @default.
• W3204159204 hasConceptScore W3204159204C2992922752 @default.
• W3204159204 hasConceptScore W3204159204C2993353421 @default.
• W3204159204 hasConceptScore W3204159204C71924100 @default.
• W3204159204 hasIssue "5" @default.
• W3204159204 hasLocation W32041592041 @default.
• W3204159204 hasLocation W32041592042 @default.
• W3204159204 hasLocation W32041592043 @default.
• W3204159204 hasOpenAccess W3204159204 @default.
• W3204159204 hasPrimaryLocation W32041592041 @default.
• W3204159204 hasRelatedWork W2509102166 @default.
• W3204159204 hasRelatedWork W2610571763 @default.
• W3204159204 hasRelatedWork W2766008196 @default.
• W3204159204 hasRelatedWork W2896659950 @default.
• W3204159204 hasRelatedWork W2944063300 @default.
• W3204159204 hasRelatedWork W2944521078 @default.
• W3204159204 hasRelatedWork W3155195005 @default.
• W3204159204 hasRelatedWork W3172359983 @default.
• W3204159204 hasRelatedWork W3204159204 @default.
• W3204159204 hasRelatedWork W4385766906 @default.
• W3204159204 hasVolume "31" @default.
• W3204159204 isParatext "false" @default.
• W3204159204 isRetracted "false" @default.
• W3204159204 magId "3204159204" @default.
• W3204159204 workType "article" @default.